Unsurprisingly, tumor cells express various receptors, such as tyrosine kinase receptor A (TrkA), TrkB, and NGF receptor (NGFR), when responding to different neuroactive molecules to activate downstream pathways. The gene discussed is NTRK1; the disease is neoplasm.